Table 3. Two hypothetical treatments (A and B).
Percentage of patients with a complete/partial tumour response | Median survival, months (95% CI) | Percentage of patients with progressive disease | Median survival, months (95% CI) | Median time to progression (months) | Median survival, months (95% CI) |
---|---|---|---|---|---|
On treatment A | On treatment A | On treatment A | |||
30 | 20 | 12 | 20 | 10 | 20 |
On treatment B | On treatment B | On treatment B | |||
40 | 22 (20–24) | 10 | 21 (20–22) | 12 | 23 (21–24) |
50 | 25 (22–28) | 8 | 22 (20–23) | 16 | 26 (23–29) |
60 | 28 (24–33) | 6 | 23 (21–25) | 20 | 29 (25–34) |
The estimated effect on survival using treatment B compared to A based on arbitrary estimates of tumour response and disease progression, and the regression analyses in Figure 1.
CI, confidence interval (based on the 95% CI of the predicted mean value in the regression analysis).